摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

isopentyl(phenyl)sulfane | 13910-11-7

中文名称
——
中文别名
——
英文名称
isopentyl(phenyl)sulfane
英文别名
3-Methylbutylsulfanylbenzene
isopentyl(phenyl)sulfane化学式
CAS
13910-11-7
化学式
C11H16S
mdl
——
分子量
180.314
InChiKey
DTADFKNTXRGGOR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    25.3
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:3ca18fac7f0539f3f315d1b1bb7f1357
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    isopentyl(phenyl)sulfane三氯化铝 作用下, 以 二硫化碳 为溶剂, 生成 2-{3-[4-(3-methyl-butylsulfanyl)-phenyl]-3-oxo-propyl}-1,1-dioxo-1,2-dihydro-1λ6-benzo[d]isothiazol-3-one
    参考文献:
    名称:
    Hannig,E., Pharmazie, 1962, vol. 17, p. 677 - 679
    摘要:
    DOI:
  • 作为产物:
    描述:
    [(3-甲基丁-2-烯-1-基)硫代]苯(1+)*CH3COO(1-) 乙醇氢气sodium 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 25.0~80.0 ℃ 、405.3 kPa 条件下, 反应 2.0h, 生成 isopentyl(phenyl)sulfane
    参考文献:
    名称:
    Low Pressure Hydrogenation of Unsaturated Sulphides with Homogeneous and Heterogeneous Ruthenium Catalysts
    摘要:
    Ru2O . nH(2)O and [Ru3O(AcO)(6)(H2O)(3)](AcO-)-Ac-+ were examined for catalytic activity in the hydrogenation of a series of unsaturated sulphides under heterogeneous and homogeneous conditions, respectively. By the appropriate combination of these two methodologies, a number of saturated sulphides could be synthesized in satisfactory to good yields, thus minimizing side reactions.
    DOI:
    10.1080/00397919608003694
点击查看最新优质反应信息

文献信息

  • An Iodine-Mediated Hofmann-Löffler-Freytag Reaction of Sulfoximines Leading to Dihydroisothiazole Oxides
    作者:Duo Zhang、Han Wang、Hanchao Cheng、José G. Hernández、Carsten Bolm
    DOI:10.1002/adsc.201701178
    日期:2017.12.19
    A Hofmann‐Löffler‐Freytag type cyclization reaction of S‐aryl‐S‐phenylpropyl sulfoximines (and related derivatives) was developed. Using molecular iodine as the initiator under visible light a series of five‐membered cyclic products was obtained in moderate to high yields. The approach represents a new strategy for the synthesis of dihydroisothiazole oxides and benzo[d]isothiazoles‐1‐oxides.
    的霍夫曼-洛夫勒-Freytag型环化反应小号-芳基-小号苯基丙基的亚磺酰亚胺(和相关的衍生物)的开发。使用分子碘作为引发剂,在可见光下可以中等至高收率获得一系列五元环状产物。该方法代表了合成二氢异噻唑氧化物和苯并[ d ]异噻唑-1-氧化物的新策略。
  • Synthesis of carboxylic acids and their methyl esters from alkyl phenyl sulphides
    作者:Carlos C. Fortes、Helena C. Fortes、Dionéia C. R. G. Gonçalves
    DOI:10.1039/c39820000857
    日期:——
    Alkyl phenyl sulphides are converted with sulphuryl chloride and pyridine under controlled temperatures into 1,1-dichloroalkyl phenyl sulphides or 1-chloroalk-1-enyl sulphides; treatment of these intermediates with methanol-water (1%v/v) and mercury(II) acetate–formic acid gives, respectively, methyl carboxylic esters and carboxylic acids.
    烷基苯基硫化物在控制的温度下与磺酰氯和吡啶转化为1,1-二氯烷基苯基硫化物或1-氯烷基-1-烯基硫化物;用甲醇-水(1%v / v)和乙酸汞(II)-甲酸处理这些中间体,分别得到甲基羧酸酯和羧酸。
  • .ALPHA.-Fluorination of Methyl Phenyl Sulfoxide and Related Compounds by Molecular Fluorine: A Novel Method for the Introduction of Fluorine into Sulfoxides Bearing .ALPHA.-H Atoms.
    作者:Akemi TOYOTA、Yoshinori ONO、Jun CHIBA、Takumichi SUGIHARA、Chikara KANEKO
    DOI:10.1248/cpb.44.703
    日期:——
    Direct formation of α-fluorosulfones from sulfoxides bearing α-H atoms merely by reaction with molecular fluorine (5% F2/N2) is reported, and a novel non-Pummerer-type mechanism is proposed for this α-fluorination reaction.
    据报道,通过与分子氟(5% F2/N2)反应,仅直接从含有α-H原子的亚砜生成α-氟磺醚,为此α-氟化反应提出了一种新型非Pummerer型机理。
  • SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
    申请人:Old David W.
    公开号:US20100093729A1
    公开(公告)日:2010-04-15
    A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    本文揭示了一种包含或其药用可接受的盐、前药或代谢产物的化合物。Y、A和B如本文所述。还公开了与这些化合物相关的方法、组合物和药物。
  • Therapeutic Compounds
    申请人:Donde Yariv
    公开号:US20090281104A1
    公开(公告)日:2009-11-12
    Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    本发明涉及包含J、B、Y和A的化合物,或其药用可接受的盐或前药。同时还公开了相关的方法、组合物和药物。
查看更多